Skip to content
The Policy VaultThe Policy Vault

tetrabenazineMedical Mutual

Tourette Syndrome and related Tic Disorders

Initial criteria

  • Patient age ≥ 18 years
  • Medication is prescribed by or in consultation with a neurologist

Reauthorization criteria

  • Response to therapy is required for continuation of therapy

Approval duration

1 year